ChengDa Pharmaceuticals Co. Ltd. (301201) — Capital Reinvestment Ratio
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Capital Reinvestment Ratio of 2.03x as of December 2025, meaning it reinvests 2% of its operating cash flow (CN¥34.02 Million) in capital expenditures (CN¥69.02 Million). Check ChengDa Pharmaceuticals Co. Ltd. (301201) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ChengDa Pharmaceuticals Co. Ltd. Capital Reinvestment Ratio (2019–2025)
This chart tracks ChengDa Pharmaceuticals Co. Ltd.'s Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see 301201 cash generation efficiency.
Annual Capital Reinvestment Ratio for ChengDa Pharmaceuticals Co. Ltd. (2019–2025)
Year-by-year Capital Reinvestment Ratio for ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2025. See 301201 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.03x | CN¥34.02 Million | CN¥69.02 Million | ▼ -79.7% |
| 2024 | 10.00x | CN¥28.65 Million | CN¥286.36 Million | ▲ +754.6% |
| 2023 | 1.17x | CN¥192.07 Million | CN¥224.67 Million | ▼ -72.9% |
| 2022 | 4.32x | CN¥47.67 Million | CN¥205.69 Million | ▲ +158.7% |
| 2021 | 1.67x | CN¥83.14 Million | CN¥138.70 Million | ▲ +237.2% |
| 2020 | 0.49x | CN¥128.97 Million | CN¥63.81 Million | ▼ -34.6% |
| 2019 | 0.76x | CN¥67.52 Million | CN¥51.06 Million | — |